Antonio Durando
- Cancer Research top 5%
- Breast Cancer Treatment Studies 20
- Oncology top 5%
- Cancer Treatment and Pharmacology 16
- HER2/EGFR in Cancer Research 11
- Peptidase Inhibition and Analysis 4
- Pathology and Forensic Medicine top 10%
- Breast Lesions and Carcinomas 5
-
- Estrogen and related hormone effects 4
- Dermatology top 10%
-
- Advanced Breast Cancer Therapies 10
-
- Neuroendocrine Tumor Research Advances 3
Antonio Durando
41 papers receiving 948 citations
Peers
Comparison fields: 5 of 72
- Cancer Research 509
- Oncology 516
- Pathology and Forensic Medicine 137
- Genetics 146
- Dermatology 43
Countries citing papers authored by Antonio Durando
This map shows the geographic impact of Antonio Durando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Durando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Durando more than expected).
Fields of papers citing papers by Antonio Durando
This network shows the impact of papers produced by Antonio Durando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Durando. The network helps show where Antonio Durando may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Antonio Durando, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2021 | 1 | |
| 3 | 2019 | 11 | |
| 4 | 2019 | 12 | |
| 5 | 2015 | 11 | |
| 6 | 2013 | 16 | |
| 7 | 2013 | 11 | |
| 8 | 2010 | 166 | |
| 9 | 2009 | 15 | |
| 10 | 2008 | 213 | |
| 11 | 2008 | 23 | |
| 12 | 2007 | 12 | |
| 13 | 2006 | 3 | |
| 14 | 2005 | 20 | |
| 15 | 2004 | 36 | |
| 16 | 2003 | 17 | |
| 17 | 2001 | 14 | |
| 18 | 1998 | 1 | |
| 19 | 1996 | 2 | |
| 20 | [Uterine hypoplasia and infertility]. | 1989 | 0 |
About Antonio Durando
Antonio Durando is a scholar working on Cancer Research, Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Biotechnology, having authored 42 papers that have together received 976 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (20 papers), Cancer Treatment and Pharmacology (16 papers), HER2/EGFR in Cancer Research (11 papers), Advanced Breast Cancer Therapies (10 papers), Breast Lesions and Carcinomas (5 papers), Estrogen and related hormone effects (4 papers), Peptidase Inhibition and Analysis (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). The work is most often cited by research in Cancer Research (509 citations), Oncology (516 citations), Pathology and Forensic Medicine (137 citations), Genetics (146 citations) and Dermatology (43 citations). Antonio Durando has collaborated with scholars based in Italy, United States and Switzerland. Frequent co-authors include Riccardo Arisio, Dionyssios Katsaros, Michela Donadio, Lina Mu, Herbert Yu, Lingeng Lu, Mario Preti, Biyun Qian, Saverio Danese and Anna Sapino. Their work appears in journals such as Journal of Clinical Oncology, Breast Cancer Research and Treatment, Annals of Oncology, Cancer and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.